Gilead Sciences
Latest statistics and disclosures from Gilead Sciences's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ACLX, RCUS, GLPG, ASMB, KYTX, and represent 99.74% of Gilead Sciences's stock portfolio.
- Reduced shares in these 1 stock: XLO (-$71M).
- Gilead Sciences was a net seller of stock by $-71M.
- Gilead Sciences has $2.1B in assets under management (AUM), dropping by 9.42%.
- Central Index Key (CIK): 0000882095
Tip: Access up to 7 years of quarterly data
Positions held by Gilead Sciences consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Gilead Sciences
Gilead Sciences holds 6 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Arcellx (ACLX) | 36.4 | $772M | 6.7M | 114.82 |
|
|
| Arcus Biosciences Incorporated (RCUS) | 32.1 | $679M | 31M | 21.60 |
|
|
| Galapagos NV Spon Adr (GLPG) | 23.7 | $501M | 17M | 30.00 |
|
|
| Assembly Biosciences Com New (ASMB) | 5.9 | $125M | 4.5M | 27.75 |
|
|
| Kyverna Therapeutics (KYTX) | 1.7 | $36M | 4.1M | 8.63 |
|
|
| Xilio Therapeutics (XLO) | 0.3 | $5.5M | -92% | 650k | 8.41 |
|
Past Filings by Gilead Sciences
SEC 13F filings are viewable for Gilead Sciences going back to 2024
- Gilead Sciences 2026 Q1 filed May 8, 2026
- Gilead Sciences 2025 Q4 filed Feb. 12, 2026
- Gilead Sciences 2025 Q3 filed Nov. 13, 2025
- Gilead Sciences 2025 Q2 filed Aug. 14, 2025
- Gilead Sciences 2025 Q1 filed May 13, 2025
- Gilead Sciences 2024 Q4 filed Feb. 13, 2025